TransCode shareholders approve warrant adjustments and share issuance at special meeting

Transcode Therapeutics, Inc.

Proposal One approved: full issuance of shares upon exercise of Series C and D warrants with floor price of $2.4882.
Proposal Two approved: adjournment if needed to solicit more votes; not used as Proposal One passed.
Vote on Proposal One: 130,226 for, 51,288 against, 8,722 abstained; 190,236 shares present (quorum).
Total shares entitled to vote: 523,261; no broker non-votes on either proposal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.